|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.830 USD | +1.05% |
|
+5.23% | -11.67% |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 05-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
EPS & Dividend: Bolt Biotherapeutics, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -59.4 | -47.2 | -36.6 | -33 | -17.85 | -18.94 | -12.37 | -15.42 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 98.000 | 26.000 | 22.400 | 10.702 | 5.468 | 4.830 | 4.830 | 4.830 |
| Nbr of stocks (in thousands) | 1,864 | 1,883 | 1,898 | 1,914 | 1,919 | 1,922 | - | - |
| Announcement Date | 30/03/22 | 29/03/23 | 21/03/24 | 24/03/25 | 12/03/26 | - | - | - |
1USD in Million2USD
Estimates
Past dividends: Bolt Biotherapeutics, Inc.
| 09/06/2025 | Significant Split/Dividend | 05:00 |
Upcoming Events: Bolt Biotherapeutics, Inc.
| 10/06/2026 | Annual General Meeting | Day | |
| 10/06/2026 | Présentation aux Actionnaires / Analystes | 19:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | -0.26x | - | - | |
| 0.06% | 0.12% | 29.16x | 5.55x | 7.52x | |
| 1.65% | 1.85% | 18.03x | 3.48x | 5.52x | |
| -.--% | -.--% | -43.89x | 68.4x | 14.68x | |
| -.--% | -.--% | -17.83x | 1.07x | 3.4x | |
| -.--% | -.--% | 22.17x | 2.18x | 4.39x | |
| -.--% | -.--% | 22.89x | 2.56x | 4.47x | |
| -.--% | 0.02% | 792.18x | 11.48x | 18.69x | |
| -.--% | -.--% | -16.21x | 193.05x | 4164.82x | |
| -.--% | -.--% | -456.21x | 18.65x | 32.71x | |
| Average | 0.19% | 0.22% | 35.00x | 34.05x | 472.91x | |
| Weighted average by Cap. | 0.37% | 0.43% | 31.35x | 24.66x | 279.11x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition